18263-Leukemia-NA-129

Leukemia

A Phase 2, Multicenter, Single-arm Study of Zanubrutinib (BGB-3111) in Patients with Previously Treated B-Cell Lymphoma Intolerant of Prior Treatment with Ibrutinib and/or Acalabrutinib (BGB-3111-215)

  • Details

ClinicalTrials.gov ID: NCT03206918
Diagnosis Type: NA
USOR Number: 18263

  • Address

1800 Williams St, Suite 200
Denver, CO 80218
P: (303) 388-4876

Find a Clinical Trial

Search by practice name, trial titles, indicators and specific disease types.